Home
News
Screeners
Insights
Parnax Lab
128.
05
-5.00
(-3.76%)
Market Cap
₹147.06 Cr
PE Ratio
12.96
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-3.76%
1M
-19.54%
6M
+8.56%
1Y
-1.50%
5Y
+459.17%
View Company Insights
Latest news about Parnax Lab
Parnax Lab promoters Mihir, Prakash Shah acquire stakes via inter-se gift
5 hrs ago
Today
Parnax Lab promoters Mihir Prakash Shah and Prakash Mahasukhlal Shah acquired stakes via inter-se gifts from Baiju Shah and Ila B. Shah respectively. The transactions, executed in July 2026, involved no monetary consideration and did not alter the consolidated promoter holding. All regulatory filings under SEBI Takeover and Insider Trading regulations were completed by August 2026.
Parnax Lab seeks approval for director re-appointment
Jul 09, 2026
Parnax Lab promoter acquires 3.15% stake via inter-se gift transfer
Jun 27, 2026
Parnax Lab reports FY26 net profit of ₹1,177.68 lakh
May 28, 2026
Parnax Lab board meets May 28 to consider Q4, FY26 results
May 20, 2026
More news about Parnax Lab
08
Apr 26
Parnax Lab Ltd. Submits Quarterly Compliance Certificate for Q4 FY26 to BSE
Parnax Lab Ltd. filed its Q4 FY26 compliance certificate with BSE on April 8, 2026, confirming no dematerialization requests were received during the quarter ended March 31, 2026. The filing, made under SEBI Regulation 74(5), was verified by registrar MUFG Intime India Private Limited and signed by Company Secretary Preet Kukreja, demonstrating adherence to mandatory quarterly compliance requirements.
15
Feb 26
Parnax Lab Limited Reports Strong Q3FY26 Results with 56.45% Revenue Growth
Parnax Lab Limited announced robust Q3FY26 financial results with consolidated revenue from operations reaching ₹6,294.15 lakhs, marking a 56.45% year-on-year growth. The company's consolidated net profit surged 124.29% to ₹271.47 lakhs, while standalone operations showed even stronger growth with revenue increasing 174.58% to ₹270.82 lakhs and net profit jumping 349.43% to ₹70.91 lakhs.
Parnax Lab
128.
05
-
5.
00
(-
3.
76
%)
1 Year Returns:
-1.50%
Industry Peers
Sun Pharmaceutical
1,930.00
(-
0.
10
%)
Divis Laboratories
8,477.00
(-
0.
27
%)
Torrent Pharmaceuticals
4,833.00
(-
1.
66
%)
Cipla
1,450.00
(-
0.
60
%)
Zydus Life Science
1,135.20
(-
2.
75
%)
Lupin
2,235.00
(-
0.
68
%)
Dr Reddys Laboratories
1,200.00
(-
0.
50
%)
Mankind Pharma
2,425.20
(+
0.
87
%)
Laurus Labs
1,787.30
(-
3.
48
%)
Aurobindo Pharma
1,622.10
(-
2.
48
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar